Filter by
News (349)
RSS
Following the renewed request from the European Commission on 27 January 2021, pharmaceutical company AstraZeneca has agreed to publish the redacted contract signed between the two parties on 27 August 2020.
Call for Tenders – Environmental Legal Register and Compliance Assessment for the European Commission’s Representation / Europe House in Valletta
Today the Commission proposed an update to the Council Recommendation of last October coordinating measures affecting free movement in the European Union. This is part of the Commission's ongoing efforts to ensure better coordination and communication of travel-related measures at EU level.
Two days ahead of the meeting of European leaders on a coordinated response to the COVID-19 crisis, the Commission set out a number of actions needed to step up the fight against the pandemic.
Today, the Commission launched the design phase of the New European Bauhaus initiative, announced by President von der Leyen in her 2020 State of the Union address. The New European Bauhaus is an environmental, economic and cultural project, aiming to combine design, sustainability, accessibility, a
Today, the European Commission concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19. The envisaged contract with Valneva would provide for the possibility for all EU Member States to purchase together 30 million doses,
As of today, small and medium-sized businesses (SMEs) can apply for financing under a €20 million grant scheme to help EU companies to make better use of intellectual property rights.
The European Commission today proposed to the EU Member States to purchase an additional 200 million doses of the COVID-19 vaccine produced by BioNTech and Pfizer, with the option to acquire another 100 million doses
Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Moderna, the second COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effect
Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by BioNTech and Pfizer, making it the first COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment